TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2010 (Business Wire) BOULDER, Colo.----Array BioPharma Inc. today reported financial results for the third quarter of fiscal 2010. us.rd.yahoo.com |
5 Reasons Why Amarin Is My Top Buy Mike Havrilla submits:Amarin Corp. (NASDAQ:AMRN) is developing AMR101 (Ethyl-EPA) as a prescription-grade omega-3 fatty acid that has been marketed in Japan for over 10 years as EPADEL by Mochida Pharma (MCPMF.PK). Ethyl-EPA is differentiated from Glaxo's (NYSE:GSK) $1 billion dollar product LOVAZA (omega-3-acid ethyl esters) in the following key areas:no fishy smell/taste or GI side effects such as burping = better patient compliance since these are both taken every daylacks Ethyl-DHA omega-3 fatty acid component, which can raise bad cholesterol (LDL) levelspotential to address a much larger patient population including those with triglyceride levels of 200-500 mg/dL vs. LOVAZA, which is indicated for patients with triglyceride levels greater than 500 mg/dLAmarin is fully funded through a potential NDA filing with ongoing partnership discussions. My current estimate is for patient enrollment to conclude by late 2010 to early 2011 (ahead of the most recent company guidance) with results expected by mid-2011 under this scenario since both studies have 12-week treatment periods. It should also be noted that both studies are being conducted under Special Protocol Assessments with the FDA without the need for Phase 2 studies, supported by over 10 years of use in Japan and previous studies conducted by Amarin for a variety of neurological conditions. Complete Story » seekingalpha.com |
Women Succeeding with Epilepsy - Video Women Help Women Live and Cope with a Chronic Medical Condition in the Family feedproxy.google.com |
China's Mindray Eyes U.S. While Western companies like GE and Philips sell expensive medical equipment in emerging markets, Chinese upstart Mindray is moving into their backyard with machines that cost 40% less than mainstream alternatives. online.wsj.com |
Parental Role Aids Anorexia Recovery Anorexia patients' families, once considered partly to blame for adolescents succumbing to the dangerous eating disorder, are increasingly being incorporated into the solution. online.wsj.com |